25.1 C
Byron Shire
January 28, 2021

Breakthrough lung cancer medication listed on PBS

Latest News

It’s legal to grow and distribute – but only by the anointed

Byron based medicinal cannabis producer is sending cannabis to Germany in a breakthrough $92m deal yet the humble plant remains illegal for locals and continues to put people behind bars.

Other News

New look and feel for Echonetdaily readers

Every old Echonetdaily is renewed again – the face of our online presence has had a lift as we...

Good advertising

Carole Gamble, Mullumbimby Creek The advertisement inside this week’s Echo and is now circulating throughout our region 'If you are tired...

Freedom of speech

Desmond Bellamy – Special Projects Coordinator, PETA Australia – Byron Bay  Great to see the deputy prime minister declaring his...

How the study of dolphin airways could help save endangered whales

Paul Bibby A new study exploring the health of dolphin airways has revealed findings that could help save endangered whale...

Conspiracy and pubs

Art Burroughes, Mullumbimby Regarding my article Conspiracy in the Pub becomes talking point (Echo, 20 January). How can we avoid falling foul...

Rail trail debate

Geoff Meers, Suffolk Park It was good to read David Lisle’s comprehensive and reasoned discussion of the history of the...

The Australian government has announced that a significant lung cancer treatment option that costs approximately $88,000 a year will soon be available for as little as $6.60 per script, thanks to its expanded listing on the Pharmaceutical Benefits Scheme (PBS).

From 1 January 2021, Australians living with non-small cell lung cancer who have not had prior therapy will benefit from the listing of Tagrisso® (osimertinib).

Without the PBS subsidy, patients might pay close to $8,000 per script or almost $88,000 per year for this treatment.

An average of 1,120 patients per year could now pay as little as $41.30 per script, or $6.60 with a concession card.

Tagrisso® is a ‘targeted therapy,’ which works on specific types of cancer cells where a specific mutation is present, to block the growth and spread of these cancer cells.

Following expert medical advice, the Government is expanding access to this breakthrough medicine for the first-line treatment of patients with metastatic non-small cell lung cancer, who have a certain type of mutation in the lungs, known as Epidermal Growth Factor Receptor (EGFR) positive.

Tagrisso acts by blocking the activity of the EGFR, which causes growth and uncontrolled division of cancer cells.

An oral therapy, Tagrisso will help patients experience an improved quality of life, and see them able to access the treatment at home and not in the hospital.

The Australian Institute of Health and Welfare estimates that more than 13,000 new cases of lung cancer will be diagnosed in 2020. It is the fifth most common cancer diagnosed in Australia.

This listing was recommended by the independent Pharmaceutical Benefits Advisory Committee.

Since 2013, the Australian Government has approved more than 2,450 new or amended listings on the PBS. This represents an average of around 30 listings or amendments per month – or one each day – at an overall investment by the Government of $12 billion.


Support The Echo

Keeping the community together and the community voice loud and clear is what The Echo is about. More than ever we need your help to keep this voice alive and thriving in the community.

Like all businesses we are struggling to keep food on the table of all our local and hard working journalists, artists, sales, delivery and drudges who keep the news coming out to you both in the newspaper and online. If you can spare a few dollars a week – or maybe more – we would appreciate all the support you are able to give to keep the voice of independent, local journalism alive.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Rail trail debate

Geoff Meers, Suffolk Park It was good to read David Lisle’s comprehensive and reasoned discussion of the history of the Casino to Murwillumbah rail corridor....

No respect

Chibo Mertineit, Lillian Rock Once again it’s that time of the year where we are meant to celebrate Australia day on 26 January. The day...

A window of trust

Baden Offord, Ocean Shores Wholeheartedly agree with Dave Rastovich’s spot-on letter regarding the value and benefit of The Echo, that it is a ‘trusted window’ (Letters,...

Conspiracy and pubs

Art Burroughes, Mullumbimby Regarding my article Conspiracy in the Pub becomes talking point (Echo, 20 January). How can we avoid falling foul of the growing tsunami of...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -